10,287 followers
A Phase I clinical study in healthy volunteers assessed the safety, tolerability, pharmacokinetics & bioavailability of ND0701, a novel formulation of apomorphine for subcutaneous infusion for #Parkinsons. Direct comparison made with APO-go® https://t.